DOCSLIB.ORG

Screening Automated Whole Breast Ultrasound

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Screening Automated Whole Breast Ultrasound Screening Automated Whole Breast Ultrasound Screening Automated Whole Breast Ultrasound Stanford now offers screening automated whole breast ultrasound (SAWBU) at our Stanford Medicine Cancer Center Palo Alto location. This is an optional test that can be used as a supplement to screening mammography in women with mammographically dense breasts. It can find cancers that cannot be seen on mammograms due to overlap with dense breast tissue. Stanford uses automated whole breast technique, a new method developed for accuracy and efficiency. Who is a candidate for SAWBU What will happen during the How is SAWBU exam is examination? SAWBU examination? different? This is an optional test to supplement You will lie on your back, and gel will Screening automated screening mammography in women be applied to your breast. whole breast ultrasound who: uses sound waves (no radi- A large ultrasound handpiece will be • Undergo routine screening with ation) to create 3D pictures placed on the breast, and the system mammography. of the breast tissue, using will automatically take a “sweep” • Have no current signs or a new automated method that obtains ultrasound images of symptoms of breast cancer. developed for accuracy and the tissue from top to bottom. The • Have mammographically dense efficiency. handpiece will be repositioned to take (heterogeneously or extremely other “sweeps” to include all of the It can find cancers that dense) breasts. breast tissue. cannot be seen on mam- • Are not at “high risk" undergoing mograms alone due to supplemental screening with An exam of both breasts takes less overlap with dense breast breast MRI. Screening ultra- than 20 minutes to obtain. tissue. sound does not provide benefit in women having breast MRI. After you depart, the radiologist will • Do not have a pacemaker or review and interpret the exam. defibrillator. Radiology Screening Wellness Program · Insurance Coverage: Some payers may not cover SAWBU and coverage may be subject to co-pays and deductibles. If exam is denied, please contact Patient Financial Services to request the self-pay pricing. · Self-Pay Pricing: Self-Pay Pricing for eligible patients after discount $550 for bilateral breasts (technical & professional fees). Pricing is subject to change without notice. (Internal Use Only CPT 76641 /IMGBI0104) Breast Density Stanford Breast Imaging ■ International Experts false positives than full-field digital mammography What is breast density? Why is breast density important? Our radiologists and imaging specialists are (FFDM). Breasts are made up of a mixture of fibrous Having dense breast tissue may slightly increase internationally renowned experts in Breast Imaging Whatand glandularis breast density?tissue and fatty tissue. Your yourWhy risk is breastof getting density breast important? cancer. Family & Intervention C-View Synthesized 2D Software Whatbreasts is breast are considered density? dense if you have a lot historyWhy is and breast other density risk factors important? may place you at The C-View software option creates synthesized 2D Breasts are made up of a mixture of fi brous and glandular Having dense breast tissue may increase your risk of getting Breastsof fibrous are made orup ofglandular a mixture oftissue fi brous but and notglandular much anHaving increased dense breast risk factor tissue may for increase breast your cancer risk of other getting images from tomosynthesis data sets. C-View images tissue and fatty tissue. Your breasts are considered dense if breast cancer. Dense breasts also make it more diffi cult for Section Chief, Mammography tissue and fatty tissue. Your breasts are considered dense if breast cancer. Dense breasts also make it more diffi cult for may be used with tomosynthesis in the screening and youfat. have Density a lot of fi maybrous decreaseor glandular with tissue age, but not but much there fat. thandoctors breast to spot density. cancer on Dense mammograms. breasts Dense also tissuemake appears Debra Ikeda, MD you have a lot of fi brous or glandular tissue but not much fat. doctors to spot cancer on mammograms. Dense tissue appears Densityis little, may decreaseif any, change with age, inbut most there iswomen. little, if any, it whitemore on difficult a mammogram. for Lumps,doctors both to benign spot andcancer cancerous, on Professor of Radiology diagnosis of breast cancer, eliminating the need for a Density may decrease with age, but there is little, if any, white on a mammogram. Lumps, both benign and cancerous, change in most women. mammograms.also appear white. DenseSo, mammograms tissue appears can be less white accurate in separate 2D exposure. changeHow in domost I women.know if I have dense breasts? also appear white. So, mammograms can be less accurate in onwomen a mammogram. with dense breasts. Lumps, both benign and Breast density is determined by the radiologist women with dense breasts. Director of Breast MRI Service The radiation dose with tomosynthesis and C-View How do I know if I have dense breasts? cancerous, also appear white. So, mammograms Howwho do reads I know your if mammogram. I have dense There breasts? are four Bruce Daniel, MD offers the clinical benefits of tomosynthesis at about Breast density is determined by the radiologist who reads your canIf Ibe have less accuratedense breasts, in women do withI still dense need Breast density is determined by the radiologist who reads your If I have dense breasts, do I still need Professor of Radiology the same average dose of 2D digital mammograms in mammogram.categories There of mammographic are four categories of density. mammographic The density. a mammogram? mammogram. There are four categories of mammographic density. breasts.a mammogram? the USA. Theradiologist radiologist assigns assigns each each mammogram mammogram to one of theto categories.one The radiologist assigns each mammogram to one of the categories. Yes. A mammogram is the only medical imaging screening test Yourof doctor the categories. should be able Your to tell doctor you whether should you havebe able Yes. A mammogram is the only medical imaging screening test Your doctor should be able to tell you whether you have proven to reduce breast cancer deaths. Many cancers are seen Diagnostic Radiology Digital Mammography dense breasts based on where you fall on the density scale. Areproven there to reduce any breast tests cancer that deaths. are Manybetter cancers than are aseen denseto tellbreasts you based whether on where you you have fall on dense the density breasts scale. on mammograms even if you have dense breast tissue. Sunita Pal, MD Digital mammography, also called full-field digital (See scale below.) mammogramon mammograms even for ifdense you have breasts? dense breast tissue. (Seebased scale below.)on where you fall on the density scale. mammography (FFDM), uses a low dose x-ray sys- In dense breasts, cancer can be hard to see on Clinical Assistant Professor of Radiology (See scale below.) Are there any tests that are better than tem to take pictures of the breasts electronically rather Radiologists classify breast density using a 4-level density scale: a mammogram.a mammogram Magnetic for dense resonance breasts? imaging What is breast density? Radiologists classify breast density using a 4-level density scale: a mammogram for dense breasts? than with film. Radiologists read the mammograms (MRI)In breasts and that to are a lesserdense, cancerextent, can ultrasound be hard to see can on a Diagnostic Radiology Breasts are made up of a mixture of fibrous and glandular and fatty tissue. In breasts that are dense, cancer can be hard to see on a for early detection and diagnosis of breast diseases in findmammogram. breast cancers Studies have that shown can’t that be ultrasoundseen on aand Jafi Lipson, MD mammogram. Studies have shown that ultrasound and women. Stanford also uses computer-aided detection Your breasts are considered dense if you have more fibrous or glandular tissue mammogram.magnetic resonance However, imaging MRI (MRI) and can ultrasoundhelp fi nd breast Assistant Professor of Radiology magnetic resonance imaging (MRI) can help fi nd breast (CAD) on the mammograms, which uses a computer but not much fat. cancers that can’t be seen on a mammogram. However, both MRI showcancers findings that can’t thatbe seen are on nota mammogram. cancer, which However, can both MRI program and neural networks to find cancer. and ultrasound, show more fi ndings that are not cancer, which resultand ultrasound, in added show testing more andfi ndings unnecessary that are not cancer, biopsies. which can result in added testing and unnecessary biopsies. Also, the Diagnostic Radiology Also,can result the costin added of testingultrasound and unnecessary and MRI biopsies. may Also,not thebe Breast Ultrasound How do I know if I have dense breasts? cost of ultrasound and MRI may not be covered by insurance. Linda Nayeli Morimoto, MD Almost entirely Scattered areas Heterogeneously Extremely dense coveredcost of ultrasound by insurance. and MRI may not be covered by insurance. Ultrasonography, which is sometimes called Breast density is determined by the radiologist who interprets your mammo- Almostfatty entirely ofScattered fi broglandular areas Heterogeneouslydense Extremely dense Clinical Instructor of Radiology fatty of fi broglandulardensity dense sonography, uses high-frequency sound waves and density gram and assigns one of four defined categories of mammographic density What should I do if I have dense breasts? a computer to create images. The primary use of WhatWhat should shouldif I don’t? I Ido do if if I Ihave have dense dense breasts? breasts? (see scale to the right.) Your mammogram report will include your assigned Breast density in the U.S. (See pie chart) What if I don’t? ■ State-of-the-Art Technology breast ultrasound today is to help diagnose breast BreastBreast density density in the in U.S. the (See U.S. pie (See chart) pie chart) What if I don’t? • 10% of women have almost entirely fatty breasts If you have dense breasts, please talk to your doctor.
Load more

Recommended publications
  • Future of Breast Elastography
    Future of breast elastography Richard Gary Barr1,2 1Department of Radiology, Northeastern Ohio Medical University, Rootstown, OH; 2Southwoods Imaging, Youngstown, OH, USA REVIEW ARTICLE Both strain elastography and shear wave elastography have been shown to have high sensitivity https://doi.org/10.14366/usg.18053 pISSN: 2288-5919 • eISSN: 2288-5943 and specificity for characterizing breast lesions as benign or malignant. Training is important for Ultrasonography 2019;38:93-105 both strain and shear wave elastography. The unique feature of benign lesions measuring smaller on elastography than B-mode imaging and malignant lesions appearing larger on elastography is an important feature for characterization of breast masses. There are several artifacts which can contain diagnostic information or alert to technique problems. Both strain and shear wave elastography continue to have improvements and new techniques will soon be available for Received: September 21, 2018 clinical use that may provide additional diagnostic information. This paper reviews the present Revised: January 4, 2019 Accepted: January 4, 2019 state of breast elastography and discusses future techniques that are not yet in clinical practice. Correspondence to: Richard Gary Barr, MD, PhD, Keywords: Breast; Elasticity imaging techniques; Strain; Shear wave; Strain ratio; Southwoods Imaging, 7623 Market Street, Youngstown, OH 44512, USA Breast neoplasms Tel. +1-330-965-5100 Fax. +1-330-965-5109 E-mail: [email protected] Introduction The use of palpation to determine the stiffness of a lesion has been used since the time of the ancient Greeks and Egyptians [1]. Stiff, non-mobile lesions of the breast have a high probability of being malignant.
    [Show full text]
  • Understanding Cost & Coverage Issues with Diagnostic Breast Imaging
    Understanding Cost & Coverage Issues with Diagnostic Breast Imaging JANUARY 2019 The following report represents key findings from The Martec Group’s primary and secondary research efforts. The team was instructed to explore the cost and coverage issue with breast diagnostic imaging in order to equip Susan G. Komen with the information necessary to strategize efforts at the state and federal levels. TABLE OF CONTENTS: I. A Brief Summary of Findings ................................................................................................................... 3 II. Project Background ..................................................................................................................................... 3 III. Study Objectives ........................................................................................................................................... 3 IV. Research Methodology .............................................................................................................................. 3 V. Patient Perspective ...................................................................................................................................... 4 VI. Health/Insurance Professional Perspective ...................................................................................... 5 VII. Cost Analysis .................................................................................................................................................. 6 VIII. Study Conclusions .......................................................................................................................................
    [Show full text]
  • Breast MRI: New and Abbreviated Protocols
    Breast MRI: New and Abbreviated Protocols Christopher Comstock M.D. Department of Radiology Memorial Sloan-Kettering Cancer Center Topics • What is our goal? • Current status of screening • How do we change screening • Abbreviated Breast MRI (AB-MR) • EA1141 AB-MR Trial • Multiparametric Breast MRI Beyond the scope of this talk! • The debate over screening the benefit of mammography, particularly for women in their forties. What is Our Goal? • Decrease breast cancer mortality • Reduction in the morbidities associated with surgery and chemotherapy • Finding breast cancers at a smaller size and earlier stage leads to a reduction in mortality and the use of less aggressive therapies Reservoir of Breast Cancer Present in 1000 Women Being Screened • Is it 30, 40, 50, 60 or more breast cancers per 1000 women? • Depends on risk of population • Detection level (size and stage) depends on modality and frequency of screening Reservoir of Breast Cancer Present in 1000 Women Being Screened Tomo plus WBUS The Dissemination of Medical Technologies into Clinical Practice • Innovations medical in technology and quality of information are the sole driving force in the acceptance and adoption of new technologies • The dissemination of medical technologies depends on the social, political and ideological context into which they are introduced Much Can Be Learned From the History of Mammography • Despite improvements in technology, mammography languished from 1930s to 1970 – 1930-1950 Stafford L. Warren, Jacob Gershon-Cohen and Raul Leborgne – 1950s Improved techniques, Robert Egan • The production of better data alone did not eliminate the role that economics, authority and ideology played “TO SEE TODAY WITH THE EYES OF TOMORROW” A HISTORY OF SCREENING MAMMOGRAPHY.
    [Show full text]
  • Breast Elastography – Ultrasound Or Magnetic Resonance
    Medical Policy Joint Medical Policies are a source for BCBSM and BCN medical policy information only. These documents are not to be used to determine benefits or reimbursement. Please reference the appropriate certificate or contract for benefit information. This policy may be updated and is therefore subject to change. *Current Policy Effective Date: 7/1/21 (See policy history boxes for previous effective dates) Title: Breast Elastography – Ultrasound or Magnetic Resonance Description/Background In the United States, about 1 in 8 women will develop invasive breast cancer over the course of her lifetime. In 2020, is it estimated that there will be over 280,000 new cases of invasive breast cancer diagnosed in women and over 2,600 new cases of invasive breast cancer in men.1 Breast cancer is the most common cancer in women worldwide.2 Mammography remains the generally accepted standard diagnostic test for breast cancer screening and diagnosis. The incidence of breast cancer has led to research on new diagnostic imaging techniques for early diagnosis. Elasticity is the property of a substance to be deformed in response to an external force and to resume its original size and shape when the force is removed. In evaluation of superficial tissue such as skin, breast or prostate, manual palpation can distinguish normal tissue from stiffer tissue. Elastography is a noninvasive technique that evaluates the elastic properties, or stiffness of tissues, and its application for diagnosing breast cancer is based on the principle that malignant tissue is less elastic than normal, healthy breast tissue. Elastography has been investigated as an additive technique to increase the specificity of ultrasound and magnetic resonance imaging.
    [Show full text]
  • Breast Ultrasound Accreditation Program Requirements
    Breast Ultrasound Accreditation Program Requirements OVERVIEW ........................................................................................................................................................................... 1 MANDATORY ACCREDITATION TIME REQUIREMENTS .......................................................................................................... 2 PERSONNEL QUALIFICATIONS ..................................................................................................................................... 2 INTERPRETING PHYSICIAN .................................................................................................................................................... 2 SONOGRAPHER/TECHNOLOGIST ........................................................................................................................................... 5 EQUIPMENT ......................................................................................................................................................................... 5 QUALITY CONTROL .......................................................................................................................................................... 6 ACCEPTANCE TESTING ......................................................................................................................................................... 6 ANNUAL SURVEY ................................................................................................................................................................
    [Show full text]
  • Evaluation of Nipple Discharge
    New 2016 American College of Radiology ACR Appropriateness Criteria® Evaluation of Nipple Discharge Variant 1: Physiologic nipple discharge. Female of any age. Initial imaging examination. Radiologic Procedure Rating Comments RRL* Mammography diagnostic 1 See references [2,4-7]. ☢☢ Digital breast tomosynthesis diagnostic 1 See references [2,4-7]. ☢☢ US breast 1 See references [2,4-7]. O MRI breast without and with IV contrast 1 See references [2,4-7]. O MRI breast without IV contrast 1 See references [2,4-7]. O FDG-PEM 1 See references [2,4-7]. ☢☢☢☢ Sestamibi MBI 1 See references [2,4-7]. ☢☢☢ Ductography 1 See references [2,4-7]. ☢☢ Image-guided core biopsy breast 1 See references [2,4-7]. Varies Image-guided fine needle aspiration breast 1 Varies *Relative Rating Scale: 1,2,3 Usually not appropriate; 4,5,6 May be appropriate; 7,8,9 Usually appropriate Radiation Level Variant 2: Pathologic nipple discharge. Male or female 40 years of age or older. Initial imaging examination. Radiologic Procedure Rating Comments RRL* See references [3,6,8,10,13,14,16,25- Mammography diagnostic 9 29,32,34,42-44,71-73]. ☢☢ See references [3,6,8,10,13,14,16,25- Digital breast tomosynthesis diagnostic 9 29,32,34,42-44,71-73]. ☢☢ US is usually complementary to mammography. It can be an alternative to mammography if the patient had a recent US breast 9 mammogram or is pregnant. See O references [3,5,10,12,13,16,25,30,31,45- 49]. MRI breast without and with IV contrast 1 See references [3,8,23,24,35,46,51-55].
    [Show full text]
  • Evaluation of the Quantitative Accuracy of a Commercially-Available Positron Emission Mammography Scanner
    The Texas Medical Center Library DigitalCommons@TMC The University of Texas MD Anderson Cancer Center UTHealth Graduate School of The University of Texas MD Anderson Cancer Biomedical Sciences Dissertations and Theses Center UTHealth Graduate School of (Open Access) Biomedical Sciences 8-2010 EVALUATION OF THE QUANTITATIVE ACCURACY OF A COMMERCIALLY-AVAILABLE POSITRON EMISSION MAMMOGRAPHY SCANNER Adam Springer Follow this and additional works at: https://digitalcommons.library.tmc.edu/utgsbs_dissertations Part of the Diagnosis Commons, Equipment and Supplies Commons, and the Other Medical Sciences Commons Recommended Citation Springer, Adam, "EVALUATION OF THE QUANTITATIVE ACCURACY OF A COMMERCIALLY-AVAILABLE POSITRON EMISSION MAMMOGRAPHY SCANNER" (2010). The University of Texas MD Anderson Cancer Center UTHealth Graduate School of Biomedical Sciences Dissertations and Theses (Open Access). 64. https://digitalcommons.library.tmc.edu/utgsbs_dissertations/64 This Thesis (MS) is brought to you for free and open access by the The University of Texas MD Anderson Cancer Center UTHealth Graduate School of Biomedical Sciences at DigitalCommons@TMC. It has been accepted for inclusion in The University of Texas MD Anderson Cancer Center UTHealth Graduate School of Biomedical Sciences Dissertations and Theses (Open Access) by an authorized administrator of DigitalCommons@TMC. For more information, please contact [email protected]. EVALUATION OF THE QUANTITATIVE ACCURACY OF A COMMERCIALLY- AVAILABLE POSITRON EMISSION MAMMOGRAPHY SCANNER
    [Show full text]
  • Commercial Reimbursement and Utilization for Invenia ABUS (Automated Breast Ultrasound)
    Commercial Reimbursement and Utilization for Invenia ABUS (Automated Breast Ultrasound) Background interpreting physician, referring physician/Health Care Provider (HCP), and patient.6 Specifically, the MQSA encourages education More than one-half of women younger than 50 years old and and outreach to patients from medical/scientific organizations, approximately one-third of women 50 years and older have industry, and interpreting physicians. In addition, outreach to dense breasts in the US.1 Higher breast density is associated referring physicians is encouraged from professional organizations with decreased mammographic sensitivity and specificity and and Continuing Medical Education (CME) providers.6 increased breast cancer risk.2 Due to the shortcomings of mammography in this population of women, an individualized Despite widely available options for additional screening and multimodal screening approach is recommended to improve the legislation mandating density inform, uptake and adoption of early detection of breast cancer. No clinical guidelines explicitly supplemental screening has lagged. In addition to knowledge recommend use of supplemental breast cancer screening on gaps, one study identified reimbursement uncertainties (e.g. women with dense breasts,3 but as of March 2018, 33 states have billing, coding and coverage) as a key factor for slow uptake. In enacted legislation requiring that breast density, in addition to 2015, the CPT® codebook was updated to include two new codes mammography results, be reported to women undergoing such for breast ultrasound, CPT 76641 and 76642, for complete and procedures; additional states have introduced or are currently limited exams, respectively.7 These codes replaced CPT 76645. working on legislation.4 Most states require specific density The new and old codes alike do not differentiate the technology inform language distinguishing dense (i.e., BI-RADS® C and D) used to perform an exam (handheld vs.
    [Show full text]
  • Shear Wave Elastography As an Early Indicator of Breast Cancer in A
    ISSN: 2378-3656 Altunkeser and Arslan. Clin Med Rev Case Rep 2019, 6:259 DOI: 10.23937/2378-3656/1410259 Volume 6 | Issue 3 Clinical Medical Reviews Open Access and Case Reports CAse RepoRt Shear Wave Elastography as an Early Indicator of Breast Cancer in a Breastfeeding Patient: A Case Report and Literature Review Ayşegül Altunkeser and Fatma Zeynep Arslan* Check for Department of Radiology, Konya Training and Research Hospital, University of Health Science, Turkey updates *Corresponding author: Fatma Zeynep Arslan, MD, Konya Training and Research Hospital, University of Health Science, Hacı Şaban Mah, Meram Yeni Yol Caddesi, No: 97, PC: 42090, Meram, Konya, Turkey, Tel: 0506-438-24-30, Fax: 0-332- 323-67-23 our hospital complaining from pain in the right breast. Abstract In the young patient with no history of cancer in the Shear wave elastography (SWE) is a relatively new and family; The patient was breasfeeding and labaratuary highly effective method to reveal mechanical features of tissue by demonstrating quantitative elasticity value. The findings were normal. On physical examination, a hard morphological features including margin of the lesion, ori- mass was palpated in her right breast. A hypoechoic entation, shape and border are considered in differentiation mass lesions was sonographically detected on the right of breast lesions on USG. It is a known fact that malignant breast in a diameter with 31 × 24 mm (Figure 1). SWE lesions are usually palpated as a hard mass in the physi- cal examination. A qualitative broad information can obtain was performed to obtain additional information about about the tissue elasticity by integrating SWE examination mass lesion.
    [Show full text]
  • Breast Imaging Faqs
    Breast Imaging Frequently Asked Questions Update 2021 The following Q&As address Medicare guidelines on the reporting of breast imaging procedures. Private payer guidelines may vary from Medicare guidelines and from payer to payer; therefore, please be sure to check with your private payers on their specific breast imaging guidelines. Q: What differentiates a diagnostic from a screening mammography procedure? Medicare’s definitions of screening and diagnostic mammography, as noted in the Centers for Medicare and Medicaid’s (CMS’) National Coverage Determination database, and the American College of Radiology’s (ACR’s) definitions, as stated in the ACR Practice Parameter of Screening and Diagnostic Mammography, are provided as a means of differentiating diagnostic from screening mammography procedures. Although Medicare’s definitions are consistent with those from the ACR, the ACR's definitions of screening and diagnostic mammography offer additional insight into what may be included in these procedures. Please go to the CMS and ACR Web site links noted below for more in- depth information about these studies. Medicare Definitions (per the CMS National Coverage Determination for Mammograms 220.4) “A diagnostic mammogram is a radiologic procedure furnished to a man or woman with signs and symptoms of breast disease, or a personal history of breast cancer, or a personal history of biopsy - proven benign breast disease, and includes a physician's interpretation of the results of the procedure.” “A screening mammogram is a radiologic procedure furnished to a woman without signs or symptoms of breast disease, for the purpose of early detection of breast cancer, and includes a physician’s interpretation of the results of the procedure.
    [Show full text]
  • ACR Practice Parameter for Performance of Contrast Enhanced
    The American College of Radiology, with more than 30,000 members, is the principal organization of radiologists, radiation oncologists, and clinical medical physicists in the United States. The College is a nonprofit professional society whose primary purposes are to advance the science of radiology, improve radiologic services to the patient, study the socioeconomic aspects of the practice of radiology, and encourage continuing education for radiologists, radiation oncologists, medical physicists, and persons practicing in allied professional fields. The American College of Radiology will periodically define new practice parameters and technical standards for radiologic practice to help advance the science of radiology and to improve the quality of service to patients throughout the United States. Existing practice parameters and technical standards will be reviewed for revision or renewal, as appropriate, on their fifth anniversary or sooner, if indicated. Each practice parameter and technical standard, representing a policy statement by the College, has undergone a thorough consensus process in which it has been subjected to extensive review and approval. The practice parameters and technical standards recognize that the safe and effective use of diagnostic and therapeutic radiology requires specific training, skills, and techniques, as described in each document. Reproduction or modification of the published practice parameter and technical standard by those entities not providing these services is not authorized. Revised 2018 (Resolution 34)* ACR PRACTICE PARAMETER FOR THE PERFORMANCE OF CONTRAST- ENHANCED MAGNETIC RESONANCE IMAGING (MRI) OF THE BREAST PREAMBLE This document is an educational tool designed to assist practitioners in providing appropriate radiologic care for patients. Practice Parameters and Technical Standards are not inflexible rules or requirements of practice and are not intended, nor should they be used, to establish a legal standard of care1.
    [Show full text]
  • ACR Practice Parameter for the Performance of Whole-Breast
    The American College of Radiology, with more than 30,000 members, is the principal organization of radiologists, radiation oncologists, and clinical medical physicists in the United States. The College is a nonprofit professional society whose primary purposes are to advance the science of radiology, improve radiologic services to the patient, study the socioeconomic aspects of the practice of radiology, and encourage continuing education for radiologists, radiation oncologists, medical physicists, and persons practicing in allied professional fields. The American College of Radiology will periodically define new practice parameters and technical standards for radiologic practice to help advance the science of radiology and to improve the quality of service to patients throughout the United States. Existing practice parameters and technical standards will be reviewed for revision or renewal, as appropriate, on their fifth anniversary or sooner, if indicated. Each practice parameter and technical standard, representing a policy statement by the College, has undergone a thorough consensus process in which it has been subjected to extensive review and approval. The practice parameters and technical standards recognize that the safe and effective use of diagnostic and therapeutic radiology requires specific training, skills, and techniques, as described in each document. Reproduction or modification of the published practice parameter and technical standard by those entities not providing these services is not authorized. 2019 (Resolution 34)* ACR PRACTICE PARAMETER FOR THE PERFORMANCE OF WHOLE- BREAST ULTRASOUND FOR SCREENING AND STAGING PREAMBLE This document is an educational tool designed to assist practitioners in providing appropriate radiologic care for patients. Practice Parameters and Technical Standards are not inflexible rules or requirements of practice and are not intended, nor should they be used, to establish a legal standard of care1.
    [Show full text]